NCT Number: NCT03416257
TMAO and Atherosclerosis in HIV
In the present study, the investigators sought to prospectively examine the associations of plasma levels of TMAO (trimethylamine oxide), choline, betaine, dimethylglycine, and sarcosine with risk of incident carotid artery plaque, assessed by repeated B-mode carotid artery ultrasound imaging over a 7-year period, in women and men with and without HIV infection from the WIHS (Women Interagency HIV Study) and MACS (Multicenter Aids Cohort Study).
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Observational
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- participants who underwent carotid artery imaging for plaque assessment at a baseline visit (2004-2006) and at a follow-up visit (2011-2013).
Exclusion criteria
- a history of coronary heart disease, individuals with prevalent diabetes or prevalent carotid artery plaques at baseline
Treatment and study plan
Primary outcomes
-
incident carotid artery plaque
Time frame: 2011-2013
assessed by repeated B-mode carotid artery ultrasound imaging
Sponsors and collaborators
Lead sponsor
Albert Einstein College of Medicine
Other
Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
Registry information
Official study title
Gut Microbial-related Choline Metabolite Trimethylamine-N-oxide is Associated With Progression of Carotid Artery Atherosclerosis in HIV Infection
Important dates
- Study start
- 2004
- Primary completion
- 2013
- Study completion
- 2017
- First posted
- Jan 31, 2018
- Registry last updated
- Jun 14, 2018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The ENROUTE Transcarotid Neuroprotection System (ENROUTE Transcarotid NPS) DW-MRI Evaluation
NCT03982420
Arterial Occlusive Diseases, Brain Diseases
New Haven, Connecticut, United States
View Trial DetailsCarotid Plaque Assessment Using 18Fluorine (18F) -Sodium Fluoride Positron Emission Tomography (PET) /MR
NCT02726984
Arterial Occlusive Diseases, Brain Diseases
Bron, France
View Trial DetailsUltrasound Assessment of Atherosclerotic Plaque Burden and Cardiovascular Risk: A 10-Year Prospective Study
NCT06933745
Arterial Occlusive Diseases, Arteriosclerosis
Oslo, East, Norway
View Trial DetailsStructural Stability of Carotid Plaque and Symptomatology
NCT02476396
Arterial Occlusive Diseases, Brain Diseases
Madison, Wisconsin, United States
View Trial Details